New and emerging treatment options for biliary tract cancer
Marcus S Noel, Aram F Hezel James P Wilmot Cancer Center, University of Rochester, Rochester, NY, USA Abstract: Biliary tract cancer (BTC) is a group of relatively rare tumors with a poor prognosis. The current standard of care consists of doublet chemotherapy (platinum plus gemcitabine); however, e...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-10-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/new-and-emerging-treatment-options-for-biliary-tract-cancer-a14833 |